cisplatin,atezolizumab,carboplatin
roche
['muc ,(-much)', 'atezo', 'cisplatin', 'imvigor 130', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nct02807636', 'carboplatin', 'imvigor,11']
 phiii imvigor130 final os of #1l platinum/gem (arm a) + atezo 16.1 mos vs chemo 13.4 mos (arm c) in did not meet pre-specified primary endpoint #muc #gu23 of note, mos in controls 13.4 mos cis/gem &amp; 13.4 mos carbo/gem in large rcr cohort 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope